You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 64 No. 4, April 2007 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (12)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Movement Disorders
 •Parkinson Disease/ Parkinsonian Disorders
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Smoking, Caffeine, and Nonsteroidal Anti-inflammatory Drugs in Families With Parkinson Disease

Dana B. Hancock, BS; Eden R. Martin, PhD; Jeffrey M. Stajich, PA-C; Rita Jewett, RN; Mark A. Stacy, MD; Burton L. Scott, PhD, MD; Jeffery M. Vance, PhD, MD; William K. Scott, PhD

Arch Neurol. 2007;64(4):576-580.

Objective  To assess associations between Parkinson disease (PD) and putatively protective factors—smoking, caffeine (coffee, tea, and soft drinks), and nonsteroidal anti-inflammatory drugs (aspirin, ibuprofen, and naproxen).

Design  Family-based case-control study.

Setting  Academic medical center clinic.

Participants  A total of 356 case subjects and 317 family controls who self-reported environmental exposures.

Main Outcome Measures  Associations between PD and environmental measures (history, status, dosage, duration, and intensity) of smoking, coffee, caffeine, nonsteroidal anti-inflammatory drugs, and nonaspirin nonsteroidal anti-inflammatory drugs were examined using generalized estimating equations with an independent correlation matrix while controlling for age and sex.

Results  Individuals with PD were significantly less likely to report ever smoking (odds ratio = 0.56; 95% confidence interval, 0.41-0.78). Additional measures of smoking revealed significant inverse associations with PD (P<.05) and trends in odds ratios (P<.005). Increasing intensity of coffee drinking was inversely associated with PD (test for trend P = .05). Increasing dosage (trend P = .009) and intensity (trend P = .01) of total caffeine consumption were also inversely associated, with high dosage presenting a significant inverse association for PD (odds ratio = 0.58; 95% confidence interval, 0.34-0.99). There were no significant associations between nonsteroidal anti-inflammatory drugs and PD.

Conclusions  Inverse associations of smoking and caffeine were corroborated using families with PD, thus emphasizing smoking and caffeine as important covariates to consider in genetic studies of PD.


Author Affiliations: Center for Human Genetics (Mss Hancock and Jewett, Drs Martin, Vance, and W. K. Scott, and Mr Stajich) and Department of Medicine (Drs Martin, Stacy, B. L. Scott, Vance, and W. K. Scott), Duke University Medical Center, Durham, NC. Drs Martin, Vance, and W. K. Scott and Ms Jewett are now with the Miami Institute for Human Genomics, University of Miami, Miami, Fla.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Update on blepharospasm: Report from the BEBRF International Workshop
Hallett et al.
Neurology 2008;71:1275-1282.
ABSTRACT | FULL TEXT  

Review: Caffeine: Neuroprotective Functions in Cognition and Alzheimer's Disease
Rosso et al.
AM J ALZHEIMERS DIS OTHER DEMEN 2008;23:417-422.
ABSTRACT  

Paraxanthine, the Primary Metabolite of Caffeine, Provides Protection against Dopaminergic Cell Death via Stimulation of Ryanodine Receptor Channels
Guerreiro et al.
Mol. Pharmacol. 2008;74:980-989.
ABSTRACT | FULL TEXT  

Use of antihypertensives and the risk of Parkinson disease
Becker et al.
Neurology 2008;70:1438-1444.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.